Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Bryan Au"'
Autor:
Mona Abaoui, Axel Schambach, Michael Rothe, Aneal Khan, Jeffrey A. Medin, John S. Klassen, Ju Huang, Jack W. Rip, Michael West, Armand Keating, Lucia Lopez-Vasquez, Ronan Foley, Murtaza S. Nagree, Sandra Sirrs, Christiane Auray-Blais, Dwayne L. Barber, Michel Boutin, Bryan Au, Nicole L. Prokopishyn, Patricia V. Turner, Shaalee Dworski, C. Anthony Rupar
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 5, Iss C, Pp 241-258 (2017)
Fabry disease is a rare lysosomal storage disorder (LSD). We designed multiple recombinant lentivirus vectors (LVs) and tested their ability to engineer expression of human α-galactosidase A (α-gal A) in transduced Fabry patient CD34+ hematopoietic
Autor:
Michael Rothe, Andrea Arruda, Axel Schambach, Yuanfeng Liu, Jeffrey A. Medin, Ju Huang, Bryan Au, Dwayne L. Barber, Mark D. Minden, Christopher J. Paige
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 3, Iss C (2016)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Interleukin-12 (IL-12) is a potent cytokine that may be harnessed to treat cancer. To date, nearly 100 IL-12-based clinical trials have been initiated worldwide. Yet systemic administration of IL-12 is toxic. Different strategies are being developed
Autor:
Makoto Yoshimitsu, Jeffrey A. Medin, Nobuo Mizue, Toshihiro Takenaka, Natalia Pacienza, Xin Fan, James C.M. Wang, Bryan Au
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Fabry disease is a lysosomal storage disorder caused by a deficiency of a-galactosidase A (a-gal A) activity that results in progressive globotriaosylceramide (Gb(3)) deposition. We created a fully congenic nonobese diabetic (NOD)/severe combined imm
Autor:
Melissa Madden, Chyan-Jang Lee, Tania C. Felizardo, Badru Moloo, Jeffrey A. Medin, Ju Huang, J. Andrea McCart, David A. Jaffray, Orlay Lopez-Perez, Alyssa Goldstein, Warren D. Foltz, James C.M. Wang, Xin Fan, Bryan Au
Publikováno v:
Biomedicines
Biomedicines; Volume 4; Issue 1; Pages: 6
Biomedicines, Vol 4, Iss 1, p 6 (2016)
Biomedicines; Volume 4; Issue 1; Pages: 6
Biomedicines, Vol 4, Iss 1, p 6 (2016)
Anti-cancer immunotherapy is emerging from a nadir and demonstrating tangible benefits to patients. A variety of approaches are now employed. We are invoking antigen (Ag)-specific responses through direct injections of recombinant lentivectors (LVs)
Autor:
Mark D. Minden, Bryan Au, Dwayne L. Barber, Ju Huang, Jeffrey A. Medin, Axel Schambach, Michael Rothe, Christopher J. Paige, Yuanfeng Liu, Megan E. Nelles, Gabi Paul, Andrea Arruda
Publikováno v:
Molecular Therapy. 23
Interleukin(IL)-12 is a potent pro-inflammatory cytokine that stimulates a variety of effector cells involved in anti-tumor immunity. Systemic administration of IL-12 has associated toxicities, however. Various strategies are being developed to reduc
Autor:
Bryan Au, Gregory A. Dekaban, Vasiliki Economopoulos, Paula J. Foster, Ryan Buensuceso, Sonali N. de Chickera, John W. Barrett
Publikováno v:
Experimental and Applied Immunotherapy ISBN: 9781607619796
Molecular medicine is focusing its attention on developing immunotherapeutic strategies that engage the immune system to combat a number of human diseases, including cancer. As a result, great emphasis has been placed on enhancing existing imaging mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ada95027eb97e08651e8c294571b2ac4
https://doi.org/10.1007/978-1-60761-980-2_18
https://doi.org/10.1007/978-1-60761-980-2_18